CNSX:BIO

Bio-Rad Laboratories Stock Forecast, Price & News

Add

Compare

Today's Range N/A

50-Day Range N/A

52-Week Range N/A

Volume265,600 shs

Average VolumeN/A

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Receive BIO News and Ratings via Email

Sign-up to receive the latest news and ratings for Bio-Rad Laboratories and its competitors with MarketBeat's FREE daily newsletter.

About Bio-Rad Laboratories

Biome Grow Inc., through its subsidiaries, cultivates, produces, and distributes cannabis at Antigonish, Nova Scotia. The company is headquartered in Toronto, Canada.

BRIEF-Bio-Rad Reports Q2 2021 Financial Results
July 29, 2021 | msn.com

Bio-Rad Reports Second-Quarter 2021 Financial Results
July 29, 2021 | finance.yahoo.com

$9.3 Billion Liquid Biopsy Market 2021: Global Trends, Forecast and Competitive Analysis Report 2015-2026 - ResearchAndMarkets.com
July 29, 2021 | finance.yahoo.com

Bio-Rad, 10x Genomics settle genomics patent war
July 27, 2021 | reuters.com

Bio-Rad Laboratories earnings preview: what Wall Street is expecting
July 27, 2021 | markets.businessinsider.com

Bio-Rad Laboratories B is about to announce earnings — here's what Wall Street expects
July 27, 2021 | markets.businessinsider.com

10x Genomics Signs Global Patent Cross License Agreement with Bio-Rad
July 27, 2021 | finance.yahoo.com

Analytical instrument Market in US Market Grow with CAGR of 3%, Key Manufacturers, Future Trend, Share, Growth and Global Forecast 2024
July 23, 2021 | marketwatch.com

What’s Next For Bio-Rad Laboratories Stock After A 10% Rise In A Month?
July 20, 2021 | forbes.com

Bio-Rad to Report Second-Quarter 2021 Financial Results, Thursday, July 29, 2021
July 14, 2021 | finance.yahoo.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange CNSX
Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
Current SymbolCNSX:BIO
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.biomegrow.com
Phone416-875-8395
EmployeesN/A
Year FoundedN/A

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableOptionable

MarketRank^™

Overall MarketRank^™

0.85 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Bio-Rad Laboratories.

4.3 Community Rank

Outperform Votes
Bio-Rad Laboratories has received 21 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Bio-Rad Laboratories has received 12 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Bio-Rad Laboratories has received 63.64% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Bio-Rad Laboratories and other stocks. Vote “Outperform” if you believe BIO will outperform the S&P 500 over the long term. Vote “Underperform” if you believe BIO will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Bio-Rad Laboratories does not currently pay a dividend.
Dividend Growth
Bio-Rad Laboratories does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Bio-Rad Laboratories insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

Bio-Rad Laboratories (CNSX:BIO) Frequently Asked Questions

What stocks does MarketBeat like better than Bio-Rad Laboratories?

Wall Street analysts have given Bio-Rad Laboratories a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Bio-Rad Laboratories wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are Bio-Rad Laboratories' key executives?

Bio-Rad Laboratories' management team includes the following people:

Mr. Khurram Malik, CEO, Pres & Director
Mr. Abbey Abdiye, Chief Financial Officer (Age 46, Pay $25k)
Mr. Frank MacMaster, Pres of Highland Grow Inc.
David Callahan, Pres of The Back Home Medical Cannabis Corp.
Scott Cuthbertson, VP of Investor Relations

Who are some of Bio-Rad Laboratories' key competitors?

Some companies that are related to Bio-Rad Laboratories include Abacus Health Products (ABAHF), Acreage (ACRGF), Alliance Growers (ACG), Althea Group (AGH), Applied Biosciences (APPB), AusCann Group (AC8), Ayr Strategies (AYRSF), Blueberries Medical (BBM), Can B (CANB), Cannara Biotech (LOVE), CannPal Animal Therapeutics (CP1), Cansortium (CNTMF), Chalice Brands (GLDFF), Charlotte's Web (CWBHF) and China Auto Logistics (CALI).
View all of BIO's competitors.

What other stocks do shareholders of Bio-Rad Laboratories own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bio-Rad Laboratories investors own include Aurora Cannabis (ACB), Brookfield Property Partners (BPY), Cross Timbers Royalty Trust (CRT), InfraCap MLP ETF (AMZA), (APHA), Alliance Resource Partners (ARLP), Curaleaf (CURLF), Cannara Biotech (LOVE), Brigham Minerals (MNRL) and Arbor Realty Trust (ABR).

What is Bio-Rad Laboratories' stock symbol?

Bio-Rad Laboratories trades on the CNSX under the ticker symbol "BIO."

How do I buy shares of Bio-Rad Laboratories?

Shares of BIO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

How many employees does Bio-Rad Laboratories have?

Bio-Rad Laboratories employs 147,000 workers across the globe.

What is Bio-Rad Laboratories' official website?

The official website for Bio-Rad Laboratories is www.biomegrow.com.

How can I contact Bio-Rad Laboratories?

The company can be reached via phone at 416-875-8395.

This page was last updated on 8/4/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.